| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 26.910 | 47.677 | 26.971 | 111.658 |
| Total Income - EUR | - | - | - | - | - | - | 27.050 | 49.442 | 43.620 | 111.669 |
| Total Expenses - EUR | - | - | - | - | - | - | 16.065 | 44.239 | 36.405 | 57.715 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 10.985 | 5.203 | 7.215 | 53.955 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 10.721 | 4.735 | 6.792 | 51.780 |
| Employees | - | - | - | - | - | - | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Metabax Lazar S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 33.877 | 35.214 | 19.774 | 24.674 |
| Current Assets | - | - | - | - | - | - | 26.444 | 20.096 | 23.543 | 38.414 |
| Inventories | - | - | - | - | - | - | 2.990 | 8.037 | 17.554 | 5.133 |
| Receivables | - | - | - | - | - | - | 6.807 | 3.957 | 3.240 | 20.385 |
| Cash | - | - | - | - | - | - | 16.647 | 8.101 | 2.749 | 12.895 |
| Shareholders Funds | - | - | - | - | - | - | 10.721 | 15.490 | 22.235 | 58.630 |
| Social Capital | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Debts | - | - | - | - | - | - | 49.601 | 39.876 | 21.082 | 4.458 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2553 - 2553" | |||||||||
| CAEN Financial Year |
2562
|
|||||||||
Comments - Metabax Lazar S.r.l.